======= TOB2 =======
== Gene Information ==
* **Official Symbol**: TOB2
* **Official Name**: transducer of ERBB2, 2
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=10766|10766]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q14106|Q14106]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=TOB2&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TOB2|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/607396|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Anti-proliferative protein inhibits cell cycle progression from the G0/G1 to S phases.
|BTG|
|vitamin D receptor binding|
|negative regulation of osteoclast differentiation|
|negative regulation of myeloid leukocyte differentiation|
|regulation of osteoclast differentiation|
|negative regulation of myeloid cell differentiation|
|positive regulation of ossification|
|negative regulation of leukocyte differentiation|
|regulation of myeloid leukocyte differentiation|
|female gamete generation|
|negative regulation of hemopoiesis|
|regulation of ossification|
|regulation of myeloid cell differentiation|
|transcription corepressor activity|
|regulation of leukocyte differentiation|
|negative regulation of immune system process|
|regulation of hemopoiesis|
|negative regulation of cell population proliferation|
|gamete generation|
|negative regulation of cell differentiation|
|multicellular organismal reproductive process|
|sexual reproduction|
|multicellular organism reproduction|
|negative regulation of developmental process|
|multi-organism reproductive process|
|negative regulation of multicellular organismal process|
|negative regulation of nucleic acid-templated transcription|
|negative regulation of RNA biosynthetic process|
|negative regulation of RNA metabolic process|
|reproductive process|
|reproduction|
|negative regulation of nucleobase-containing compound metabolic process|
|negative regulation of macromolecule biosynthetic process|
|negative regulation of cellular biosynthetic process|
|negative regulation of biosynthetic process|
|regulation of cell population proliferation|
|regulation of immune system process|
|positive regulation of multicellular organismal process|
|regulation of cell differentiation|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp28|Pimelic-diphenylamide-106 5μM R00 exp28]]|-2.24|
|[[:results:exp212|Phenformin 20μM R05 exp212]]|-1.94|
|[[:results:exp321|ABT-702 5μM plus Deferoxamine 11μM R07 exp321]]|-1.83|
|[[:results:exp405|Tenofovir 10μM R07 exp405]]|-1.75|
|[[:results:exp376|Losmapimod 1μM R07 exp376]]|-1.71|
|[[:results:exp149|SB203580 25μM R03 exp149]]|1.75|
|[[:results:exp477|DKK1 89ng/ml R08 exp477]]|1.98|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 11550
* **Expression level (log2 read counts)**: 6.04
{{:chemogenomics:nalm6 dist.png?nolink |}}